Top drug regulator Richard Pazdur set to leave FDA

Taking stock of the drug industry, from the lab to the medicine chest

December 2, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

FDA STAT+ | Top drug regulator Richard Pazdur set to leave the FDA Top drug regulator Richard Pazdur filed papers to retire from the Food and Drug Administration at the end of this month. By Lizzy Lawrence Expert review finds delaying the hepatitis B vaccine birth dose would increase chronic infections in kids New report warns pushing back hepatitis B birth shots could sharply raise preventable infections. CDC vaccine panel will consider policy change this week. By Helen Branswell STAT+ | A drug that was 'engineered with AI' enters Phase 3 testing Today's biotech news includes a drug "engineered with AI" entering Phase 3 testing, a lawsuit on a hospital drug discount program, etc. By Elaine Chen Elijah Nouvelage/Getty Images Days before ACIP meeting, committee chair gets a new job at HHS Today's health news covers the U.S. silence on World AIDS Day, the ACIP committee chair's new job at HHS, and more. By Theresa Gaffney

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser